Withholding vs Maintaining aspirin prior to coronary artery bypass graft surgery; A Clinical Trial Study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N150

Enrollment

204

Registered

2020-10-31

Start date

2018-12-21

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery bypass graft surgery. Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris

Interventions

Intervention 1: Intervention group: In the first group, aspirin will continue until the day of surgery. Intervention 2: Intervention group: In the second group, it will be stopped 48 hours before the

Eligibility

Sex/Gender

All

Age

35 Years to 80 Years

Inclusion criteria

Inclusion criteria: All patients who die during surgery All patients who come to the operating room for the first time for coronary artery bypass graft All patients undergoing open heart surgery by a surgeon All patients are brought to the operating room electively

Exclusion criteria

Exclusion criteria: Patients who develop cardiac and respiratory arrest during surgery All patients who die during surgery

Design outcomes

Primary

Measure	Time frame
Bleeding. Timepoint: During operation. Method of measurement: Observation.;Mean number of postoperative FFP. Timepoint: After surgery. Method of measurement: Observation.;Mean postoperative cardiac tamponade. Timepoint: After surgery. Method of measurement: Observation.;Mean postoperative myocardial infarction. Timepoint: After surgery. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza rostami

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026